International Stem Cell (OTCMKTS:ISCO) Share Price Breaks Above 200-Day Moving Average – What’s Next?

International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $0.24 and traded as high as $0.2850. International Stem Cell shares last traded at $0.28, with a volume of 312 shares.

International Stem Cell Stock Up 5.3%

The stock has a market cap of $2.24 million, a price-to-earnings ratio of -3.50 and a beta of -0.05. The company’s fifty day moving average is $0.36 and its two-hundred day moving average is $0.24.

International Stem Cell (OTCMKTS:ISCO) last announced its quarterly earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $2.67 million during the quarter.

About International Stem Cell

International Stem Cell Corporation is a biotechnology company focused on developing therapeutic and commercial applications for human parthenogenetic stem cells. These cells are derived from unfertilized human oocytes and are intended to provide a source of pluripotent stem cells without the use of fertilized embryos.

The company has researched stem-cell-based treatments for conditions including neurological and ophthalmic disorders, while also developing cell-based technologies and related research products.